Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vimpat in pediatric focal epilepsy (1 month to <4 years)
CTR20160916Phase 3Completed
- Sponsor
- UCB
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in Focal Onset Epilepsy, Focal onset seizure, sponsored by UCB. Started May 2018; status: completed.
02
Drugs
lacosamide
03
Conditions
Focal Onset EpilepsyFocal onset seizure
Beyond the preview
Go deeper on CTR20160916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160916.